A Cheeky ScalpLet's see if the Bart pattern moves all the way down, keeping a tight stop loss below the barely holding support
Key facts today
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.75 USD
126.04 M USD
1.48 B USD
190.70 M
About Hims & Hers Health, Inc.
Sector
Industry
CEO
Andrew Dudum
Website
Headquarters
San Francisco
Founded
2017
FIGI
BBG00Q53VYM7
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Related stocks
HIMS - Potential Bearish ABCD & FVG Retest Setup (4H)\HIMS is currently showing signs of a potential bearish ABCD pattern forming, with the recent rejection at point A and retracement towards B, holding around the 1.617 Fibonacci extension level. A possible short-term bounce may occur toward point C (0.618 retracement), before continuing downward.
📉
$HIMS | Cup & Handle Setup FormingA classic cup & handle setup is building on the 4H chart.
Price just broke out of a falling channel (handle), and is now testing a key breakout zone between $48–$53. A daily close above $54–$55 with volume would confirm continuation.
I’ve mapped out three potential price targets ($73.88, $99.17,
6/25/25 - $hims - How I'm trading this for size6/25/25 :: VROCKSTAR :: NYSE:HIMS
How I'm trading this for size
- i make a lot of moves, as you can tell. but you'll also notice i tend to find positions that i like as i validate the thesis... and go massive
- NYSE:HIMS and NASDAQ:TSLA are two names that i'm not new to, but have been wrangli
HIMS off to the races to fill the gapNYSE:HIMS is off to the races to fill the upside gap. The NOVO deal that fell thru is an entry opportunity for a strong performer.
HIMS – Long Setup | Potential 60% MoveHims & Hers (HIMS) just gave us a textbook Ichimoku breakout and is holding strong above the cloud after a healthy pullback.
Technical Breakdown:
Price above Kumo Cloud: Bullish structure intact.
Support held at $54.62 – key base above cloud and Tenkan-sen.
MACD is curling back after a corrective
Safe Entry Zone HIMS Part-2After the 150%+ profit reached. in part-0
Stock reached blue zone which was part-1 analysis target.
Now Target Reached.
Despite the termination of Novo drugs with HIMs which will hurt HIMS on long run for sure unless they figure out something.
I strongly believe despite negativity and all bad ne
$HIMSNYSE:HIMS is hovering around $45, but demand is drying up.
Buyers seem hesitant at these levels after the hype from the Novo Nordisk breakdown faded.
Without new momentum or a catalyst, we might see a correction or sideways action until confidence returns.
HIMS 1D — This pattern didn’t cook for nothingOn the daily chart of Hims & Hers Health, we’re looking at a textbook cup with handle formation — not just a pattern, but a structure backed by time, volume, and classic price behavior. The base of the cup formed steadily from February to May 2025, and as soon as the curve was complete, price transi
HIMS puked up its Wegovy today!Hims & Hers Health
HIMS
shares were down more than 34.63% in Monday trading, while Novo Nordisk
NVO stock was down over 5% after Novo Nordisk said it has halted its collaboration with Hims & Hers on the sale of weight loss drugs, including Wegovy.
The two companies launched a collaboration in A
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HIMS is 48.96 USD — it has increased by 0.92% in the past 24 hours. Watch Hims & Hers Health, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Hims & Hers Health, Inc. stocks are traded under the ticker HIMS.
HIMS stock has fallen by −4.61% compared to the previous week, the month change is a −8.95% fall, over the last year Hims & Hers Health, Inc. has showed a 134.48% increase.
We've gathered analysts' opinions on Hims & Hers Health, Inc. future price: according to them, HIMS price has a max estimate of 85.00 USD and a min estimate of 28.00 USD. Watch HIMS chart and read a more detailed Hims & Hers Health, Inc. stock forecast: see what analysts think of Hims & Hers Health, Inc. and suggest that you do with its stocks.
HIMS reached its all-time high on Feb 19, 2025 with the price of 72.98 USD, and its all-time low was 2.72 USD and was reached on May 12, 2022. View more price dynamics on HIMS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
HIMS stock is 5.21% volatile and has beta coefficient of 2.87. Track Hims & Hers Health, Inc. stock price on the chart and check out the list of the most volatile stocks — is Hims & Hers Health, Inc. there?
Today Hims & Hers Health, Inc. has the market capitalization of 10.84 B, it has increased by 7.43% over the last week.
Yes, you can track Hims & Hers Health, Inc. financials in yearly and quarterly reports right on TradingView.
Hims & Hers Health, Inc. is going to release the next earnings report on Aug 11, 2025. Keep track of upcoming events with our Earnings Calendar.
HIMS earnings for the last quarter are 0.20 USD per share, whereas the estimation was 0.12 USD resulting in a 65.41% surprise. The estimated earnings for the next quarter are 0.15 USD per share. See more details about Hims & Hers Health, Inc. earnings.
Hims & Hers Health, Inc. revenue for the last quarter amounts to 586.01 M USD, despite the estimated figure of 538.59 M USD. In the next quarter, revenue is expected to reach 549.87 M USD.
HIMS net income for the last quarter is 49.48 M USD, while the quarter before that showed 26.02 M USD of net income which accounts for 90.14% change. Track more Hims & Hers Health, Inc. financial stats to get the full picture.
No, HIMS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 8, 2025, the company has 1.64 K employees. See our rating of the largest employees — is Hims & Hers Health, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Hims & Hers Health, Inc. EBITDA is 137.93 M USD, and current EBITDA margin is 5.76%. See more stats in Hims & Hers Health, Inc. financial statements.
Like other stocks, HIMS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hims & Hers Health, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Hims & Hers Health, Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Hims & Hers Health, Inc. stock shows the buy signal. See more of Hims & Hers Health, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.